Nevertheless, despite the upregulation of BCL2A1 and BIRC3 observed in our experiment, the majority of melanoma cells died, suggesting that RGD-apoptins may be able to bypass the defense mechanisms of these tumor cells. This evidence concerns the gene BCL2A1 and neoplasm.